REVVITY, INC Excess Tax Benefit from Share-based Compensation, Operating Activities
REVVITY, INC (RVTY) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2018-02-27
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2013-12-29 was $0.00.
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2013-09-29 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2013-06-30 was $0.00.
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for fiscal 2017 was $0.00.
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for fiscal 2016 was $2.44M.
- REVVITY, INC excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $0.00.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 | ||||
| 2017-01-01 | $0.00 10-K · filed 2018-02-27 | ||||
| 2016-01-03 | $2.44M 10-K · filed 2018-02-27 | ||||
| 2014-12-28 | $0.00 10-K · filed 2017-02-28 | ||||
| 2013-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $0.00 derived: sum of 2 quarters · filed 2016-03-01 | $0.00 derived: sum of 3 quarters · filed 2016-03-01 | $0.00 10-K · filed 2016-03-01 | |
| 2013-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $0.00 10-Q · filed 2013-11-05 | -$3.53M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | -$3.53M derived: sum of 3 quarters · filed 2015-02-24 | -$2.91M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-06 | -$3.53M derived: sum of 2 quarters · filed 2015-02-24 | -$2.91M derived: sum of 3 quarters · filed 2015-02-24 | -$2.91M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2012-12-30 | -$3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$2.91M derived: sum of 2 quarters · filed 2015-02-24 | -$2.91M derived: sum of 3 quarters · filed 2015-02-24 | -$1.77M 10-K · filed 2015-02-24 | $1.77M 10-K · filed 2013-02-26 |
| 2012-09-30 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $628.00K derived: sum of 2 quarters · filed 2013-11-05 | $1.77M 10-Q · filed 2013-11-05 | $1.78M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $1.14M 10-Q · filed 2013-08-06 | $1.16M derived: sum of 3 quarters · filed 2014-02-25 | $1.87M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-04-01 | $1.14M 10-Q · filed 2013-05-06 | $1.16M derived: sum of 2 quarters · filed 2014-02-25 | $1.87M derived: sum of 3 quarters · filed 2014-02-25 | $2.69M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-01-01 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $730.00K derived: sum of 2 quarters · filed 2014-02-25 | $1.55M derived: sum of 3 quarters · filed 2014-02-25 | $9.32M 10-K · filed 2014-02-25 | |
| 2011-10-02 | $712.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.53M derived: sum of 2 quarters · filed 2012-11-06 | $9.30M 10-Q · filed 2012-11-06 | $6.82M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-07-03 | $819.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $8.59M 10-Q · filed 2012-08-07 | $6.10M derived: sum of 3 quarters · filed 2013-02-26 | $6.16M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-04-03 | $7.77M 10-Q · filed 2012-05-08 | $5.29M derived: sum of 2 quarters · filed 2013-02-26 | $5.34M derived: sum of 3 quarters · filed 2013-02-26 | $5.34M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-01-02 | -$2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$2.43M derived: sum of 2 quarters · filed 2013-02-26 | -$2.43M derived: sum of 3 quarters · filed 2013-02-26 | -$2.40M 10-K · filed 2013-02-26 | $2.40M 10-K · filed 2011-03-01 |
| 2010-10-03 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $58.00K derived: sum of 2 quarters · filed 2011-11-04 | $82.00K 10-Q · filed 2011-11-04 | ||
| 2010-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-10 | $24.00K 10-Q · filed 2011-08-10 | |||
| 2010-04-04 | $24.00K 10-Q · filed 2011-05-10 | ||||
| 2010-01-03 | -$222.00K 10-K · filed 2012-02-28 | $222.00K 10-K · filed 2011-03-01 | |||
| 2008-12-28 | $342.00K 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |